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Abstract
Background: Populations having lower socioeconomic status, as well as ethnic minorities, have demonstrated
lower utilization of preventive screening, including tests for early detection of breast and colorectal cancer.
The objective: To explore socio-demographic disparities in adherence to screening recommendations for early
detection of cancer.
Methods: The study was conducted by Maccabi Healthcare Services, an Israeli HMO (health plan) providing
healthcare services to 1.9 million members. Utilization of breast cancer (BC) and colorectal cancer (CC) screening
were analyzed by socio-economic ranks (SERs), ethnicity (Arab vs non-Arab), immigration status and ownership of
voluntarily supplemental health insurance (VSHI).
Results: Data on 157,928 and 303,330 adults, eligible for BC and CC screening, respectively, were analyzed. Those
having lower SER, Arabs, immigrants from Former Soviet Union countries and non-owners of VSHI performed fewer
cancer screening examinations compared with those having higher SER, non-Arabs, veterans and owners of VSHI
(p < 0.001). Logistic regression model for BC Screening revealed a positive association with age and ownership of
VSHI and a negative association with being an Arab and having a lower SER. The model for CC screening revealed
a positive association with age and ownership of VSHI and a negative association with being an Arab, having a
lower SER and being an immigrant. The model estimated for BC and CC screening among females revealed a
positive association with age and ownership of VSHI and a negative association with being an Arab, having a
lower SER and being an immigrant.
Conclusion: Patients from low socio-economic backgrounds, Arabs, immigrants and those who do not own
supplemental insurance do fewer tests for early detection of cancer. These sub-populations should be considered
priority populations for targeted intervention programs and improved resource allocation.
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S o c i a lj u s t i c ea f f e c t st h ew a yp e o p l el i v ea n d ,i nc o n s e -
quence, their chances of illness and risk of premature
death. Avoidable health disparities result from the cir-
cumstances in which people grow up, live, work and
age, as well as what systems put in place to deal with
health and disease [1].
During the last decade, disparities in health care have
entered the emerging debate over quality of care. In
2001, the Institute of Medicine (IOM) declared that
among other dimensions, quality of health care is also
defined by it being equitable, i.e., care that does not vary
in quality because of personal characteristics such as
gender, ethnicity, geographic location and socioeco-
nomic status [2]. This designation of equality as a
dimension in quality of care reinforced the commitment
of health organizations to reduce health disparities
among all populations. A report published by the IOM
in 2002 suggested that awareness of the health care gap
be heightened among sectors that include health care
providers, their patients and society at large [3].
Disparities in health outcomes and healthcare access and
utilization, based on ethnicity and socio-economic status,
are well documented throughout the world [3-6] as well as
in Israel [7-10]. These disparities exist despite the fact that
Israel has a universal health care system, guaranteed under
the National Health Insurance Law (NHIL), formally
declared to be based on the principles of equality, justice
and social solidarity. The system is financed through
taxation linked to income and general revenue. Health
care is provided by four non-profit health plans. Each plan
is required to provide its members with a basic benefits
package that includes community-based care as well as
hospitalization. Choice of health plans is autonomous,
with prohibition against denial of enrollment.
Preventive care, such as screening for early detection
of breast and colorectal cancer, is included in a compre-
hensive benefit package of services and are free of
charge in all the health plans. In addition, all Israeli
HMOs offer their beneficiaries the opportunity to pur-
chase, on a voluntarily basis, supplementary health
insurance to expand the basket of benefits. The tariff is
age-based and not related to health status.
Maccabi Healthcare Services (MHS) is an Israeli
health plan providing community-based health services
throughout the country to 1.9 million members from
diverse population groups. Services are provided in five
geographical regions through 150 local branches (the
basic administrative unit), and is based on a core staff of
some 4,000 independent physicians and 1,000 nurses.
Physicians are self-employed, working from either MHS
clinics located in the branches or their private offices,
usually in solo practices. Nurses, other health
professionals and administrative staff are salaried and
generally work in the branches.
Since 2004, MHS has been measuring performance in
6 clinical domains. Among the 24 quality measures used
are screening tests for the early detection of two malig-
nant diseases: Breast Cancer (BC) and Colorectal Cancer
(CC). Results of performance measures are analyzed and
reported internally on a monthly basis to central head-
quarters, regions and branches. Reporting transparency
has brought to light disparities between regions and
branches that serve different populations and raised
recognition of inequity as a significant issue, to the
point where it gradually entered the organizational dis-
course. Field staff have since identified local barriers to
quality care and constructed tailor-made interventions
that have effectively reduced disparities, such as the case
of mammography among Arab women [11].
Mammography screening for early detection of BC has
been shown to effectively reduce mortality in women
aged 50-74 regardless of screening interval or number of
mammographic views per screen [12,13]. Screening has
thus become a major recommended practice in health
organizations throughout the world as well as in Israel
[14]. Disparities in mammography use among Israeli sub
populations was previously documented in two studies,
the first a cross-sectional study initiated by MHS [15],
the second conducted by the largest Israeli HMO (Clalit
Health Services) [16]. In the first study, Baron Epel and
her colleagues suggested that the interventions imple-
mented by MHS may have increased mammography uti-
lization but had not completely eliminated disparities
between member sub populations. The second study
indicated the same pattern. These findings can be con-
firmed with Israeli CDC data, which show large differ-
ences in rates of self-reported mammography use by our
sub population groups [17].
Screening for early detection of CC: Such screening is
also universally recommended. Annual fecal occult
blood testing (FOBT) and periodic colonoscopy (every 5
years) are the common methods for CC screening
among normal-risk populations [18]. In Israel, FOBT
has been promoted nationally as the recommended pri-
mary method for screening. Since an increasing number
of health consumers and caregivers prefer colonoscopy
as their screening method of choice, both methods are
included in the measure [14]. Despite recent increases
in colorectal screening due to national programs as well
as initiatives to promote this preventive care introduced
by all four HMOs, disparities in early detection of colon
cancer are still documented [14,16].
In 2008, MHS took a strategic decision to invest in a
long-term effort to reduce disparities in health care and
health outcomes. The first step was to float core data
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members belonging to different population groups [19].
To this end, a methodology and designated database for
monitoring and ongoing analysis was constructed [20].
The hypothesis tested in the research stated that
despite the fact that breast and colorectal cancer screen-
ing in Israel is free of charge, other social and cultural
barriers influence utilization of these important exami-
nations. Hence, the current research objective was to
analyze the association of socio-economic status, immi-
gration, ethnicity (Arab vs. non-Arab) and VSHI owner-
ship with utilization of cancer screening tests.
Methods
Setting
The study was conducted by MHS.
Study Period
Data was extracted in November 15, 2008 (Due Day).
Study Population
All MHS adult members who visited their general prac-
titioner (GP) at least once during the previous two years
were eligible for inclusion in the data set. We used the
latter criterion as a proxy for a routine patient-physician
relationship in all measures that reflect care at the pri-
mary-care level. Previous analyses had revealed that 6%
of MHS members, aged 50-74, who had not visited their
GP in a 2-year period, demonstrate far less-favorable
health outcomes when compared with those who have
regular interactions with their physician; this sub-popu-
lation should therefore be analyzed separately.
Eligibility
BC screening: Women aged 52-74, (52 is the age when a
woman is expected to have utilized mammography
screening during the previous two years, i.e., since
reaching the age of 50); CC screening: men and women
aged 51-74. MHS members who had been diagnosed
with breast or colorectal cancer in the past were
excluded from the analysis.
Data sources
Data were extracted from: (1) the MHS computerized
billing system; (2) the MHS computerized Performance
Measurement System; (3) the Israeli Census for data on
socio-economic status ranks (SER) and ethnicity (Arab
vs non-Arab [21].
Definitions
Performance measures
BC Screening
Eligible women who had undergone a mammography
test at least once during the two previous years.
CC Screening
Eligible men and women who had transmitted a sample
for FOBT at least once during the previous year or had
undergone at least one colonoscopy during the previous
five years.
Independent Variables
Socio Economic Rank (SER)
Israel is administratively divided into sub-districts, each
having a population of at least 3,000 residents; each sub-
district tends to be relatively homogeneous. Sub-districts
are characterized by their socio-economic status, based on
variables such as housing density, employment, income,
education, and so forth. These ranks are updated every 15
years when a national population survey is conducted. We
used the latest information with which sub-districts are
ranked on a 1-20 scale (1-lowest, 20-highest) obtained
from the 1995 national population survey and census, car-
ried by the Central Bureau of Statistics [21]. As part of our
analysis, subjects were allocated to a sub-district according
to his/her last recorded address and then assigned a socio-
economic status, which was later collapsed into four SES
rank (SER) categories: 1-5, 6-10, 11-15, and 16-20. It is
important to note that the SER given to a MHS member
was based on residential area or sub-district rather than
personal information.
Ethnicity (Arab vs. Non-Arab)
Israeli Arabs comprise 20% of overall population [21].
They live in rural and urban, Arab and mixed localities
throughout the country. All Israeli Arabs are citizens
and entitled to equal health care services under the
NHIL. Personal data on ethnicity or income is not
transmitted to HMOs in order to avoid discrimination
or adverse selection of members. Therefore, Israeli
Arabs can be identified only by their residential locality
o r( a si nl a r g em i x e dc i t i e ss u c ha sN a z a r e t h )s u b - d i s -
trict data, recorded by the National Census [21]. Israeli
research uses this data in cases where the direct ques-
tioning of subjects is not possible [16,22]
Immigration
Starting in 1990, Israel became home to a wave of
immigration (about 1 million people) from countries
belonging to the Former Soviet Union (FSU), who con-
tributed to a 15% growth in total population during that
decade. The MHS data set contains immigration status
for FSU immigrants only. Hence, we included only these
immigrants under the category “Immigration”.W e
should note that total MHS members belonging to the
other immigrant groups arriving in recent decades are
too few in number for inclusion in this analysis as a dis-
tinct group.
VSHI
Although all Israeli citizens are insured for health care,
Israeli HMOs offer their members the opportunity to
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(VSHI), meant to enlarge the benefits package. Every
member, irrespective of health status, can purchase
VSHI; the tariff is age-based and unrelated to health sta-
tus [23]. According to reports published by the Israeli
Ministry of Health, 74.4% of all Israelis and 87.8% of
MHS beneficiaries own VSHI [24]. MHS members who
own this type of insurance tend to have a higher SER.
The lack of VSHI may therefore be regarded as a proxy
for low SER.
Data set construction
We combined MHS Billing System, PMS and Israeli
Census data into one data set using the AS400 query
system.
Statistical analysis
For all eligible subjects, we performed (A) an analysis of
variance for BC and CC screening between sub-groups
(gender, SERs, ethnicity, immigration and VSHI) using
Chi-square techniques; (B) Logistic Regression Models
were estimated for three dependent variables: (1) BC
screening (2) CC screening and (3) BC and CC screen-
ing only for females. The independent variables were
included in the models only if they reached the required
significance level (p<0.05) in the univariant analysis.
Although we had compared four ranks in the univariant
analysis, we combined SER 1-10 and 11-20 into two
separate dummy variables in the final models. Our deci-
sion was based on the preliminary models indicating
robust results only for the two more-inclusive (1-10 and
11-20) rather than the four less-inclusive (1-5; 6-10; 11-
15; 16-20) ranks. Odds ratios (OR) and 95% confidence
intervals (95%CI) were also calculated.
Ethics
T h ed a t au s e df o rt h i ss t u d ya r en o to p e n l ya v a i l a b l e ;
hence, the study did not require ethical approval
Results
We analyzed 157,928 women who were eligible for BC
screening and 303,330 men and women who were eligi-
ble for CC screening tests. Utilization of mammography
screening was more prevalent in the higher SERs (11-15,
16-20): 68.6% and 72.9%, respectively, compared to the
lower ranks (1-5, 6-10): 64.1% and 65.6%, respectively (p
< 0.001). Mammography tests was less utilized by Arab
women compared to non-Arabs: 61% and 69.1%, respec-
tively (p < 0.001); by veteran residents compared to
immigrants: 69.3% and 67.1%, respectively (p < 0.001);
and by owners of VSHI compared to non-owners: 70.9%
and 51.5%, respectively (p < 0.001) (Table 1).
The final logistic regression model for BC screening as
a dependent variable revealed a weak positive associa-
tion with age (OR: 1.004; 95%CI: 1.002-1.005) and a
robust positive association with being an owner of VSHI
(OR: 2.235; 95%CI: 2.155-2.319). Negative associations
were found with being an Arab women (OR: 0.883; 95%
CI: 0.813-0.959) and belonging to a low SER (1-10) (OR:
0.883; 95%CI: 0.860-0.907). No significant association
was found with being an immigrant from the FSU and
BC screening (Table 2).
The final logistic regression model for CC screening as
a dependent variable revealed a positive association with
age (OR: 1.038; 95%CI: 1.036-1.039) and a positive and
robust association with owning VSHI (OR: 1.824; 95%
CI: 1.757-1.885). Negative associations were found with
b e i n ga nA r a b( O R :0 . 7 8 9 ;9 5 % C I :0 . 7 3 5 - 0 . 8 4 6 ) ,b e l o n g -
ing to a lower SER (1-10) (OR: 0.774; 95%CI: 0.758-
0.791) and with being an immigrant from the FSU (OR:
0.832; 95%CI: 0.814-0.851). No statistical association was
found with gender (Table 3). We estimated a third
model for eligible females where the dependent variable
Table 1 Utilization (%) of Breast and Colon Cancer
Screening by Gender, SER, Immigration, Ethnicity and
VSHI
Variable BC
1 Screening P Value CC
2 Screening P Value
Eligible (N) 157,928 303,330
Age 52-74 51-74
Gender
Female 68.8 — 29.0 < 0.411
Male —— 28.9
SER
1-5 64.1 21.7
6-10 65.6 < 0.001 25.0 < 0.001
11-15 68.6 28.8
16-20 72.9 34.4
Ethnicity
Arabs 61.0 < 0.001 20.4 < 0.001
Non Arabs 69.1 29.3
Immigration
Immigrants 67.1 < 0.001 25.1 < 0.001
Veterans 69.3 30.0
VSHI
Owners 70.9 < 0.001 30.3 < 0.001
Non Owners 51.5 18.1
Notes:
1 Breast Cancer;
2 Colon Cancer.
Table 2 Results of Final Regression Model for Dependent
Variable: Utilization of Mammography for Breast Cancer
Screening (Women only)
Variable B SE
1 p Value OR
2 95% CI
3
Age 0.994 0.001 < 0.001 1.004 1.002-1.005
Ethnicity (Arabs) -0.124 0.042 0.003 0.883 0.813-0.959
SER 1-10 -0.125 0.014 < 0.001 0.883 0.860-0.907
Immigration 0.019 0.015 0.188 1.02 0.991-1.049
VSHI 0.804 0.019 < 0.000 2.235 2.155-2.319
Notes:
1 Standard Error;
2 Odds Ratio;
3 95% Confidence Interval.
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revealed a weak positive association with age (OR: 1.036;
95%CI: 1.034-1.038) and a robust positive association
with owning VSHI (OR: 1.991; 95%CI: 1.891-2.096). A
negative association was found with being an Arab
women (OR: 0.887; 95%CI: 0.798-0.986), having lower
SER (1-10) (OR: 0.785; 95%CI: 0.762-0.810) and being
an immigrant from the FSU (OR: 0.902; 95%CI: 0.873-
0.932) (Table 4).
Discussion
Our study identified those population sub-groups who
demonstrate less favorable health measures regarding
preventive care: men and women who belong to lower
socio-economic ranks, Arabs, who are known to be a
deprived Israeli ethnic minority, immigrants and people
who have not purchased VSHI. These MHS members
should be considered as priority populations for inter-
vention programs and resource allocation to increase
utilization of screening tests.
These findings are interesting due to the fact that
Israel has a universal health system and that the studied
examples of preventive care are highly accessible and
completely free of charge. In this case, affordability can-
not explain the variations in service uptake.
In addition, eligible MHS members are subject to var-
ious outreach efforts by our staff (physicians, nurses,
other health professionals as well as administrative staff)
to promote service utilization, such as mail invitations
to perform BC screening, telephone reminders,
scheduled appointments for mammography [11] and
transmission of FOBT kits at MHS branches when
members come for routine laboratory tests. Despite
these efforts, disparities still exist.
Our results are compatible with national statistics per-
taining to the national program for community quality
indicators, which has demonstrated low utilization of
BC but not of CC screening among persons having low
socioeconomic status [14]. In addition, our results are
compatible with those from other countries with univer-
sal health systems and national preventive care pro-
grams [25-28]. In these studies, it has been argued that
innovations in health technology may widen inequalities
if people with more knowledge, money or power have a
greater ability to harness the beneficial effects [29,30].
In low socio-economic populations, more than afford-
ability is required to take advantage of care availability
in general and preventive services in particular. Several
barriers, internal to the individual as well as within their
physical and social environment, hamper such behavior.
Moreover, even if environments are supportive, making
positive healthy choices is rather difficult for people do
not feel in control over their circumstances [31]
Baron Epel, an Israeli researcher, has suggested in her
two recently published studies that subjective norms,
fatalism, fear of breast cancer, and perceived effective-
ness are associated with mammography use. These asso-
ciations were not persistent with all the sub-population
groups she surveyed (Orthodox and secular Jews, Immi-
grants, Arabs). Each population seems to exhibit unique
values and norms, the presence of which can predict
preventive behavior [32,33]. The main conclusion emer-
ging from these studies is that the behavioral factors
relevant for each group must be investigated in-depth to
better understanding how to most effectively target
organizational resources and thus reduce disparities in
preventive care. Furthermore, it appears that tailor-
made interventions formulated and delivered by local
teams who are familiar with the specific community’s
norms, beliefs and values are likely to be very effective
[11].
Lessons learnt from a National Cancer Screening Pro-
gram in the UK, show that variations in the uptake of
breast cancer screening were closely related to social
deprivation. These findings support the theory that
societies create and shape patterns of health and disease.
Health care innovations are generally introduced within
the context of inequalities that shape the distribution of
the health benefit, thereby affecting morbidity patterns
[26,29,34,35].
Both breast and cervical cancer screening require
attendance at a clinic; hence, factors such as time pres-
sures, transport problems or discomfort in interacting
with medical services and health professionals could
Table 3 Results of the Final Regression Model for
Dependent Variable: Utilization of Colorectal Cancer
Screening (Men and Women)
Variable B SE
1 p Value OR
2 95% CI
3
Age 0.037 0.001 < 0.001 1.038 1.036-1.039
Gender (male) -0.012 0.009 < 0.187 1.012 0.994-1.030
Ethnicity (Arabs) -0.237 0.036 < 0.001 0.789 0.735-0.846
SER 1-10 -0.256 0.011 < 0.001 0.774 0.758-0.791
Immigration -0.183 0.012 < 0.001 0.832 0.814-0.851
VSHI 0.601 0.017 < 0.001 1.824 1.756-1.885
Notes:
1 Standard Error;
2 Odds Ratio;
3 95% Confidence Interval.
Table 4 Results of Final Regression Model for Dependent
Variable: Performing CC Screening and BC Screening
(Women).
Variable B SE
1 p Value OR
2 95% CI
3
Age 0.036 0.001 < 0.001 1.036 1.034-1.038
Ethnicity (Arabs) -0.120 0.054 0.026 0.887 0.798-0.986
SER 1-10 -0.241 0.016 < 0.001 0.785 0.762-0.810
Immigration -0.103 0.017 < 0.001 0.902 0.873-0.932
VSHI 0.688 0.026 < 0.001 1.991 1.891-2.096
1 Standard Error;
2 Odds Ratio;
3 95% Confidence Interval.
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utilization [36]. In some countries, a “Patient Naviga-
tion” (PN) method has been implemented, mainly for
deprived populations, to assist people in obtaining can-
cer information, screening, treatment, and support ser-
vices. This method provides people from weak segments
of the populations with a “bridge” facilitating their inter-
action with the healthcare system. When combined with
additional methods, such as educational programs, over-
all effectiveness may increase [37].
At this point we can conclude that multifactor inter-
ventions that target more than one aspect of the screen-
ing process are likely to have greater effects. The largest
challenge for future research will be to identify those
methods that address the moral, cultural, educational
and other personal resources involved in motivating
screening uptake.
Our findings suggest that MHS members who did not
purchase VSHI were less likely to perform screening
tests. Lack of VSHI is an indicator of deprivation, and
not a causal factor for lower utilization of care since
VSHI ownership does not affect accessibility or afford-
ability of BC and CC screening tests.
Israeli Arabs belong to an ethnic minority represent-
ing about 20% of Israel’s current population. They gen-
erally belong to the lowest socioeconomic ranks. As
Israeli citizens, they are entitled to equal health ser-
vices. However, previous studies indicate that this sub-
population suffers from major disparities in health care
utilization and health outcomes [11,14]. A study con-
ducted by an Israeli group of researchers in one of
northern Israel’s largest hospitals providing services to
a major proportion of Arabs suggests that Arab
patients were more likely to be obese and to have
diabetes. A greater percentage of Arab patients also
suffered higher rates of stroke [38]. However, tailored-
made interventions to increase use of mammography
by Arab women [11] reduced but did not completely
eliminated differences between Arabs and other Israeli
ethnic groups [15].
Recent studies conducted with participants from the
Palestinian Authority and from Israel have reported a
combination of personal, cultural, normative and con-
ceptual factors that act as barriers to BC screening [39].
The begged-for conclusion is that any intervention
aimed at this ethnic sub population must be tailor-
made.
With respect to immigration, our study identified
immigrants from FSU countries as a population at risk
for lower utilization of cancer screening. This group is
characterized by its high educational level, relatively
good assimilation into Israeli society and relatively long
residence (10 years and more) at the time of the study.
An earlier study carried out by Remennick and collea-
gues suggests that although FSU immigrant women
acknowledged the personal risks and understood the
role of screening, they still avoided taking preventive
action [40]. In 2003, the same author demonstrated the
low priority of preventive health on the personal agenda
of female immigrants from the FSU, who appeared to be
burdened by more immediate survival needs (income,
housing, care of other family members, etc.). Other bar-
riers identified were the lack of referrals from primary
care providers, fear of cancer diagnosis, apprehensions
regarding irradiation and the pain associated mammo-
graphy, a generally fatalistic attitude towards health and
illness, and mistrust of current cancer therapy [41].
These studies indicate that personal barriers may also
play a major role in cancer screening utilization.
Our study has therefore identified priority populations
for special organizational attention and efforts aimed at
reducing health disparities. A methodology for the
investigation of barriers to equitable care and tailoring
solutions to these barriers has been implemented and
tested since early 2010. Among the key factors distin-
guishing this methodology are: (1) Training of MHS
staff in cultural competency in order to better under-
stand the social, ethnic, religious needs and preferences
of unique populations. In this respect we view poverty
as a culture that influences one’s health choices and pre-
ferences; (2) Translation of educational materials regard-
ing preventive care into Arabic and Russian in order to
overcome language barriers. For better linguistic accessi-
bility, an organization-wide medical interpreting and
translation service, using low-tech technology (the tele-
phone) has recently been implemented; and (3)
Increased accessibility of preventive services, obtained
by using methods such as a mobile mammography unit,
which is sent to remote and rural areas where transpor-
tation difficulties create barriers.
The study’s added value
First, disparities in utilization of preventive care are
well-documented. However, in Israel, the current
research is one of very few attempts to describe this
phenomenon through analysis of an extensive database
hosted by a large HMO. This study therefore sheds
greater light on disparities existing in a society where
financial barriers to preventive care do not exist.
Second, in a world where health organizations are
challenged by wise allocation of scarce resources, it is
important to carefully identify priority populations. This
study helped MHS to redefine its organizational strategy
regarding how every decision is made by filtering the
process through the lens asking how much the decision
will contribute to disparities reduction.
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Eligibility
Our subjects were eligible for participation in the study
if they had visited their GP at least once during the pre-
vious two years. Six percent of our beneficiaries did not
meet this criterion. We do not consider this to be the
result of a selection bias since previous studies have sug-
gested that this group demonstrated unique health out-
comes characteristics and therefore should be
investigated separately.
Ethnicity
T h ee t h n i ci d e n t i t yo fm e m b e r si sn o ta v a i l a b l et o
HMOs for historical reasons, mainly to avoid discrimi-
nation. Hence, we identified Arab members by area of
residence. We estimate that 90% of this sub population
was thereby identified and thus participated in our
study. We should note that Israeli Arabs live mainly in
almost exclusively Arab settlements. For those who live
in mixed cities such as Nazareth, we obtained informa-
tion about sub-districts, which include populations of
3,000 inhabitants, while assuming that neighborhoods
are more or less homogeneous.
SER
Because data on socio-economic variables such as edu-
cation, income and housing conditions are not directly
available to Israeli HMOs on the personal level, we
could classify our members only according to the SERs
assigned to their locality. Undoubtedly, averaging the
values of these variables for a 3,000-member sub district
can never be as accurate as personal datasets. Analysis
of the Israeli data supports the validity of using district
SER as a proxy for personal SER [42].
Conclusion
Preventive care has been positively associated with
socioeconomic status and the ownership of voluntarily
supplemental health insurance, and negatively associated
with immigration and Arab ethnicity. These factors do
not, by themselves, fully explain low utilization of pre-
ventive health care services. Hence, the other factors
that tentatively influence healthy behavior and lifestyle
should be investigated in depth before planning any
intervention program.
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